NICE Recommends Infliximab And Adalimumab For The Treatment Of Severe, Active Crohn's Disease
Links shared publicly online about this topic.
- 1,338total visits
NICE Recommends Infliximab And Adalimumab For The Treatment Of Severe, Active Crohn's Disease
View full resource at medicalnewstoday.com
Tags: IBD, Crohn's Disease, Crohn's Disease Medication, Ulcerative Colitis Medication, Rheumatoid Arthritis Medication, Disease and Condition, Remicade, Humira
Most Recently Shared on March 5, 2010 at 6:09 am By:
NICE Recommends Infliximab And Adalimumab For The Treatment Of Severe, Active Crohn's Disease http://mnt.to/3yv6 #gastrointestinal
Also Shared By:
NICE recommends infliximab and adalimumab for Crohn's disease treatment | News | Nursing Times
nursingtimes.net — “In final draft guidance published today (4 March) NICE has recommended infliximab and adalimumab as treatment options for people with severe, active Crohn's disease whose condition has not responded to conventional therapy, or who are intolerant of or have contraindications to conventional therapy.” View full resource at nursingtimes.net
Most Recently Shared on March 4, 2010 at 11:55 am By:
News: NICE recommends infliximab and adalimumab for Crohn's disease treatment http://bit.ly/dvpjj3
Advertisement
medical_tweets
@medical_tweets
NICE Recommends Infliximab And Adalimumab For The Treatment Of Severe, Active Crohn's Disease In final draft guidance.. http://bit.ly/cAsG7S
1 year ago...